INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,181,659 | +52.7% | 363,630 | +3.1% | 0.00% | +33.3% |
| Q2 2023 | $6,014,523 | 0.0% | 352,758 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,014,523 | -15.3% | 352,758 | -0.7% | 0.00% | -25.0% |
| Q4 2022 | $7,100,352 | -99.9% | 355,373 | +8.1% | 0.00% | 0.0% |
| Q3 2022 | $7,078,691,000 | -20.5% | 328,630 | -27.2% | 0.00% | -20.0% |
| Q2 2022 | $8,902,927,000 | -17.5% | 451,467 | -1.6% | 0.01% | 0.0% |
| Q1 2022 | $10,785,445,000 | +207.2% | 458,955 | +256.1% | 0.01% | +400.0% |
| Q4 2021 | $3,510,964,000 | +10.5% | 128,890 | +11.7% | 0.00% | 0.0% |
| Q3 2021 | $3,178,115,000 | -9.2% | 115,400 | -6.2% | 0.00% | 0.0% |
| Q2 2021 | $3,500,581,000 | -11.7% | 123,000 | +5.7% | 0.00% | -50.0% |
| Q1 2021 | $3,964,720,000 | +4.6% | 116,404 | +2.2% | 0.00% | 0.0% |
| Q4 2020 | $3,791,831,000 | +13.8% | 113,903 | +9.9% | 0.00% | 0.0% |
| Q3 2020 | $3,330,862,000 | +14.3% | 103,636 | -2.0% | 0.00% | 0.0% |
| Q2 2020 | $2,913,759,000 | +81.5% | 105,801 | +5.6% | 0.00% | +100.0% |
| Q1 2020 | $1,605,533,000 | -25.2% | 100,158 | +11.4% | 0.00% | 0.0% |
| Q4 2019 | $2,146,167,000 | +37.8% | 89,873 | +1.8% | 0.00% | 0.0% |
| Q3 2019 | $1,557,471,000 | -17.0% | 88,292 | +20.5% | 0.00% | 0.0% |
| Q2 2019 | $1,875,481,000 | +38.3% | 73,261 | +57.1% | 0.00% | 0.0% |
| Q1 2019 | $1,355,679,000 | +160.1% | 46,635 | +17.4% | 0.00% | – |
| Q4 2018 | $521,127,000 | -48.3% | 39,720 | -20.3% | 0.00% | -100.0% |
| Q3 2018 | $1,007,422,000 | -14.9% | 49,823 | -0.5% | 0.00% | 0.0% |
| Q2 2018 | $1,184,062,000 | -1.7% | 50,066 | -6.4% | 0.00% | 0.0% |
| Q1 2018 | $1,204,911,000 | -15.9% | 53,504 | +16.5% | 0.00% | 0.0% |
| Q4 2017 | $1,432,378,000 | +79.3% | 45,939 | +79.5% | 0.00% | 0.0% |
| Q3 2017 | $798,820,000 | +327.1% | 25,595 | +134.8% | 0.00% | – |
| Q2 2017 | $187,044,000 | +55238.5% | 10,900 | -53.2% | 0.00% | – |
| Q3 2016 | $338,000 | +47.0% | 23,300 | 0.0% | 0.00% | – |
| Q2 2016 | $230,000 | -22.0% | 23,300 | 0.0% | 0.00% | – |
| Q1 2016 | $295,000 | -56.6% | 23,300 | -37.7% | 0.00% | -100.0% |
| Q4 2015 | $679,000 | -2.2% | 37,400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $694,000 | -13.8% | 37,400 | +13.3% | 0.00% | 0.0% |
| Q2 2015 | $805,000 | +182.5% | 33,000 | +140.9% | 0.00% | – |
| Q1 2015 | $285,000 | +45.4% | 13,700 | +7.9% | 0.00% | – |
| Q4 2014 | $196,000 | +47.4% | 12,700 | +24.5% | 0.00% | – |
| Q3 2014 | $133,000 | -34.8% | 10,200 | 0.0% | 0.00% | – |
| Q2 2014 | $204,000 | -96.7% | 10,200 | -97.2% | 0.00% | -100.0% |
| Q4 2013 | $6,141,000 | – | 361,044 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |